Insulin-Like Growth Factor-I Improves Glucose and Lipid-Metabolism in Type-2 Diabetes-Mellitus
There is no official FDA-approved indication for GLP-1 receptor agonists in treating joint pain, and these medications are not classified as analgesics or anti-inflammatory agents
While weight loss certainly drives some reductions in inflammatory markers, GLP-1 medicines appear to do far more
"Any medication that sees this rapid adoption warrants close examination, particularly in orthopedics where obesity and surgical intervention often overlap, and when the long-term effects of GLP-1 RA exposure on bone and joint health remain poorly understood."Press ReleaseMore Information.Sign up for our weekly HealthDay newsletter
A professional can help ensure that supplements dont interact with any medications you may be taking and can recommend an appropriate dosage to meet your needs
DOI: 10.15515/abr.0976-4585.6.3.120-123 Sadighara M, Joktaji JP, Hajhashemi V, Minaiyan M